Low-dose Cytarabine for Acute Myeloid Leukaemia (AML)

What's in this booklet? 

Cytarabine (also called cytosine arabinoside or Ara-C) is a treatment for leukaemia, particularly acute myeloid leukaemia (AML). It can be administered at different doses, generally referred to as ‘high’, ‘intermediate’ and ‘low’. High and intermediate dose cytarabine are generally used as part of the intensive chemotherapy treatment of AML. Low-dose cytarabine generally refers to the doses of cytarabine commonly used in the non-intensive treatment of AML, either alone or in combination with other drugs

This hardcopy version of our booklet can be ordered free of charge to UK addresses. 

Digital downloads

To access an instant download of our Low-dose cytarabine for Acute myeloid leukaemia (AML) information booklet, please click here (opens as a PDF file). 

Each booklet takes us approximately six months to write and is supplied free of charge to patients, families and hospitals across the UK. It costs us approximately £3 to provide one booklet. Please consider adding a donation to your order if you can.